Allergies News and Research

Latest Allergies News and Research

A hospital ER charges an ‘after-hours’ fee. Who has to pay it?

This week, I responded to readers who were unhappy with their health plan's decision not to pay an emergency department surcharge for after-hours care and concerned about difficulties getting Medicare to cover claims unrelated to a workers' compensation injury.

5 Jun 2018

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

4 Jun 2018

NIH study unravels how tularemia bacteria trick host cells to cause disease

Scientists from the National Institute of Allergy and Infectious Diseases--part of the National Institutes of Health--have unraveled the process by which the bacteria cause disease.

31 May 2018

Scientists develop natural, non-toxic hair dye from blackcurrant skins

Whether they're trying to hide some gray or embrace a new or quirky color, people adore hair dyes. But some of these dyes may be harmful to humans and the environment.

30 May 2018

New environmental monitoring project finds increased numbers of deer ticks in Southern Indiana

A new environmental monitoring project at Indiana University has found increased numbers of the ticks that carry Lyme disease in Southern Indiana.

25 May 2018

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.

25 May 2018

Allergies can have serious, far-reaching consequences on adolescents

Although allergies affect more than 50 million Americans, they are occasionally misunderstood and can be seen as a minor condition. An article published in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology shows allergies can have serious, far-reaching consequences, especially on adolescent sufferers.

24 May 2018

NIH commences first-in-human trial evaluating experimental treatment for Ebola

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

24 May 2018

Study identifies key food allergy policies that parents want in schools to improve safety of kids

One in five parents did not feel that their child with food allergy was safe while at school, according to results of a national survey published in BMC Pediatrics.

23 May 2018

Penn investigators discover source of immune molecule involved in nasal polyps, asthma

A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies.

23 May 2018

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

21 May 2018

Ozone exposure at birth linked to increased risk of developing asthma in childhood

A long-term study of the health of Canadian children has found that exposure to ozone (O3), a common air pollutant, at birth was associated with an 82 percent increased risk of developing asthma by age three.

21 May 2018

Clinical trial begins enrollment to test safety of experimental MERS treatments

Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).

18 May 2018

Microglia may play key role in slowing progression of prion diseases, research suggests

Prion diseases are slow degenerative brain diseases that occur in people and various other mammals. No vaccines or treatments are available, and these diseases are almost always fatal. Scientists have found little evidence of a protective immune response to prion infections.

17 May 2018

Researchers explore different strategies to keep kids with asthma out of hospital

Pediatric asthma takes a heavy toll on patients and families alike. Affecting more than 7 million children in the U.S., it's the most common nonsurgical diagnosis for pediatric hospital admission, with costs of more than $570 million annually.

16 May 2018

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

The most severe allergic reaction, anaphylaxis, is the result of an inappropriate immune reaction following the introduction of a usually harmless antigen into the body.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Allergies News and Research

Latest Allergies News and Research

A hospital ER charges an ‘after-hours’ fee. Who has to pay it?

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

NIH study unravels how tularemia bacteria trick host cells to cause disease

Scientists develop natural, non-toxic hair dye from blackcurrant skins

New environmental monitoring project finds increased numbers of deer ticks in Southern Indiana

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

Allergies can have serious, far-reaching consequences on adolescents

NIH commences first-in-human trial evaluating experimental treatment for Ebola

Study identifies key food allergy policies that parents want in schools to improve safety of kids

Penn investigators discover source of immune molecule involved in nasal polyps, asthma

Scientists identify new drug target to combat chikungunya virus

Ozone exposure at birth linked to increased risk of developing asthma in childhood

Clinical trial begins enrollment to test safety of experimental MERS treatments

Microglia may play key role in slowing progression of prion diseases, research suggests

Researchers explore different strategies to keep kids with asthma out of hospital

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

New test developed for accurate and safe diagnosis of peanut allergies

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Poison ivy and poison oak can cause mild to severe allergic reactions

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in